ERBB2 and neoplasm: Studies that have compared ERBB2 gene expression between tumors with either dim or incomplete IHC HER2 staining and negative HER2 expression have reported higher mRNA levels of ERBB2, validating the higher presence of this tyrosine kinase receptor within these tumor cells [10,11].